These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21811138)

  • 1. Prospective study of the ARCHITECTHIV Ag/Ab Combo fourth generation assay to detect HIV infection in sexually transmitted infection clinics.
    Bischof JJ; Kuruc JD; Embry JA; Hatch JE; Ashton FA; Schmitz JL; Miller WC; Leone PA; Gay CL
    AIDS; 2011 Sep; 25(15):1927-9. PubMed ID: 21811138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.
    Patel P; Mackellar D; Simmons P; Uniyal A; Gallagher K; Bennett B; Sullivan TJ; Kowalski A; Parker MM; LaLota M; Kerndt P; Sullivan PS;
    Arch Intern Med; 2010 Jan; 170(1):66-74. PubMed ID: 20065201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for acute human immunodeficiency virus infection in Baltimore public testing sites.
    Temkin E; Marsiglia VC; Hague C; Erbelding E
    Sex Transm Dis; 2011 May; 38(5):374-7. PubMed ID: 21183865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of the ADVIA Centaur(®) HIV Ag/Ab Combo assay.
    Pumarola T; Freeman J; Saxton E; Dillon P; Bal T; van Helden J
    J Virol Methods; 2010 Dec; 170(1-2):16-20. PubMed ID: 20723562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of acute infections during HIV testing in North Carolina.
    Pilcher CD; Fiscus SA; Nguyen TQ; Foust E; Wolf L; Williams D; Ashby R; O'Dowd JO; McPherson JT; Stalzer B; Hightow L; Miller WC; Eron JJ; Cohen MS; Leone PA
    N Engl J Med; 2005 May; 352(18):1873-83. PubMed ID: 15872202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2.
    Beelaert G; Fransen K
    J Virol Methods; 2010 Sep; 168(1-2):218-22. PubMed ID: 20561542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and western blot.
    Barbé F; Klein M; Badonnel Y
    Ann Biol Clin (Paris); 1994; 52(5):341-5. PubMed ID: 7856933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of sexually transmitted diseases in children and adolescents evaluated for sexual abuse in Cincinnati: rationale for limited STD testing in prepubertal girls.
    Siegel RM; Schubert CJ; Myers PA; Shapiro RA
    Pediatrics; 1995 Dec; 96(6):1090-4. PubMed ID: 7491226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting.
    Ho MK; Lo JY; Lo AC; Cheng FK; Chan FK
    Sex Transm Infect; 2009 Sep; 85(5):322-5. PubMed ID: 19406739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new fourth generation enzyme-linked immunosorbent assay, the LG HIV Ag-Ab Plus, with a combined HIV p24 antigen and anti-HIV-1/2/O screening test.
    Yeom JS; Jun G; Chang Y; Sohn MJ; Yoo S; Kim E; Ryu SH; Kang HJ; Kim YA; Ahn SY; Cha JE; Youn ST; Park JW
    J Virol Methods; 2006 Nov; 137(2):292-7. PubMed ID: 16908076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of a transcription-mediated-amplification HIV-1 RNA assay in pooled specimens.
    Zetola NM; Mintie A; Liska S; Wong E; Williams JD; Busch MP; Klausner JD
    J Clin Virol; 2007 Sep; 40(1):68-70. PubMed ID: 17662648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons for testing and clinical and demographic profile of adolescents with non-perinatally acquired HIV infection.
    Grant AM; Jamieson DJ; Elam-Evans LD; Beck-Sague C; Duerr A; Henderson SL
    Pediatrics; 2006 Mar; 117(3):e468-75. PubMed ID: 16510625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute HIV infection - New York City, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(46):1296-9. PubMed ID: 19940835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of HIV infection in Papua New Guinea.
    Babona DV; Slama G; Puiahi E
    P N G Med J; 1996 Sep; 39(3):200-4. PubMed ID: 9795563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting.
    Jensen TO; Robertson P; Whybin R; Chambers I; Lahra M; Rawlinson W; Post JJ
    J Clin Microbiol; 2015 May; 53(5):1709-11. PubMed ID: 25673794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Architect HIV Ag/Ab Combo Assay in a low-prevalence setting: The role of samples with a low S/CO ratio.
    Alonso R; Pérez-García F; Gijón P; Collazos A; Bouza E
    J Clin Virol; 2018 Jun; 103():43-47. PubMed ID: 29635210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi.
    Weber B; Orazi B; Raineri A; Thorstensson R; Bürgisser P; Mühlbacher A; Areal C; Eiras A; Villaescusa R; Camacho R; Diogo I; Roth HJ; Zahn I; Bartel J; Bossi V; Piro F; Atamasirikul K; Permpikul P; Webber L; Singh S
    Clin Lab; 2006; 52(9-10):463-73. PubMed ID: 17078473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV RNA testing in the context of nonoccupational postexposure prophylaxis.
    Roland ME; Elbeik TA; Kahn JO; Bamberger JD; Coates TJ; Krone MR; Katz MH; Busch MP; Martin JN
    J Infect Dis; 2004 Aug; 190(3):598-604. PubMed ID: 15243937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.